Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-05

Clinical Trial Update: Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating oral minoxidil for recurrent platinum-resistant epithelial ovarian cancer (Ovarian Cancer) is underway; current status is unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral Minoxidil (minoxidil)

Snippet

Sponsor: Loyola University | Conditions: Ovarian Cancer | Phase 2 | Status: UNKNOWN